ClinicalTrials.Veeva

Menu

Decreasing Long-term Opioid Use in Cancer Survivors

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Suspended

Conditions

Cancer Pain
Survivorship
Chronic Pain
Pain

Treatments

Behavioral: Acceptance and Commitment Therapy for chronic pain (ACT-CP)

Study type

Interventional

Funder types

Other

Identifiers

NCT05067556
MCC-21-18366

Details and patient eligibility

About

This is a feasibility pilot trial assessing a behavioral intervention for chronic pain among disease-free cancer survivors to decrease long-term opioid dependence.

Full description

To assess the feasibility and acceptability of implementing brief Acceptance and Commitment Therapy for chronic pain (ACT-CP) in a Survivorship clinic.

Enrollment

18 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of cancer of any type, currently in remission, having completed active primary therapy. Patients on oral adjuvant hormone therapy will still be eligible.
  • Completed active therapy must have been curative in intent (for example stage IV cancer patients such as head and neck cancer patients treated with curative intent are eligible).
  • Self-reported cancer pain for >= 3 months
  • Opioid use >= 5MME/day (morphine milligram equivalents) as prescribed by physician for cancer-related pain for at least 6 months beyond completion of their cancer treatment
  • VCUHealth system patient

Exclusion criteria

  • History of opioid use prior to cancer diagnosis
  • Anyone with prior history of substance use disorder or currently enrolled in a methadone program
  • Anyone with schizophrenia or bipolar disorder
  • Current utilization of psychotherapy services for pain, depression, anxiety, and/or PTSD
  • Cognitive concerns that would prevent meaningful engagement in treatment
  • Inability to converse in English
  • Lack of working telephone and Internet connection (must have at least one or the other)
  • Anyone found to have progression of cancer
  • Anyone diagnosed with cancer recurrence or new cancer during their study period
  • Documented diagnosis of or positive screen for current substance use disorder (score >5 on the Drug Abuse Screening Test-10 [DAST-10])
  • Anyone scoring >=8 on ORT indicating very high risk for opioid abuse

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

18 participants in 1 patient group

Intervention
Experimental group
Description:
Acceptance and Commitment Therapy for Chronic Pain (ACT-CP)
Treatment:
Behavioral: Acceptance and Commitment Therapy for chronic pain (ACT-CP)

Trial contacts and locations

1

Loading...

Central trial contact

Autumn Lanoye, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems